Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
76.79
-0.08 (-0.10%)
At close: Aug 12, 2026, 4:00 PM EDT
76.78
-0.01 (-0.01%)
After-hours: Aug 12, 2026, 4:47 PM EDT
Forte Biosciences Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Forte Biosciences stock has a consensus rating of "Hold" and an average price target of $73.8. The average 1-year stock price forecast is 3.89% lower than the current stock price, while the lowest is $61 (-20.56%) and the highest is $77 (+0.27%).
Price Target: $73.8 (-3.89%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Forte Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Downgrades $74 → $77 | Hold | Downgrades | $74 → $77 | +0.27% | Jul 28, 2026 |
| Brookline Capital Markets | Brookline Capital Markets | Hold Downgrades $77 | Hold | Downgrades | $77 | +0.27% | Jul 27, 2026 |
| Evercore ISI | Evercore ISI | Hold Downgrades $69 → $77 | Hold | Downgrades | $69 → $77 | +0.27% | Jul 27, 2026 |
| TD Cowen | TD Cowen | Hold Downgrades $77 | Hold | Downgrades | $77 | +0.27% | Jul 27, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $75 | Buy | Reiterates | $75 | -2.33% | Jul 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.83
from -4.71
EPS Next Year
-4.04
from -3.83
EPS and Forward PE are based on non-GAAP adjusted numbers.